| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |